Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Pharmos (PARS) -- Ignore unavailable to you. Want to Upgrade?

To: yosi s who wrote (969)	1/22/2000 3:16:00 PM
From: NeuroInvestment	Read Replies (1) \| Respond to of 1386

Pharmos is doing some of the planning and designing of a Phase 2-3, but at this point, with their increased confidence regarding signing a partner during 1H:00, there is very little likelihood that they will actually start that trial. And the timeframe for the last cohort must take into consideration the fact that--following the last six month followup, some weeks of data cleanup and compilation are necessary before they actually unblind the data and have results. NeuroInvestment (www.neuroinvestment.com)